nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—melanoma	0.87	1	CbGaD
Vecuronium—Paralysis—Vemurafenib—melanoma	0.0087	0.0675	CcSEcCtD
Vecuronium—Myopathy—Temozolomide—melanoma	0.00441	0.0342	CcSEcCtD
Vecuronium—Injection site pain—Carmustine—melanoma	0.00392	0.0304	CcSEcCtD
Vecuronium—Injection site reaction—Carmustine—melanoma	0.00318	0.0246	CcSEcCtD
Vecuronium—Respiratory failure—Temozolomide—melanoma	0.00315	0.0244	CcSEcCtD
Vecuronium—Redness—Docetaxel—melanoma	0.00304	0.0236	CcSEcCtD
Vecuronium—Connective tissue disorder—Vemurafenib—melanoma	0.00298	0.0231	CcSEcCtD
Vecuronium—Cardiac disorder—Vemurafenib—melanoma	0.00282	0.0218	CcSEcCtD
Vecuronium—Angiopathy—Vemurafenib—melanoma	0.00276	0.0214	CcSEcCtD
Vecuronium—Mediastinal disorder—Vemurafenib—melanoma	0.00274	0.0212	CcSEcCtD
Vecuronium—Rash erythematous—Docetaxel—melanoma	0.00268	0.0208	CcSEcCtD
Vecuronium—Erythema—Vemurafenib—melanoma	0.00264	0.0205	CcSEcCtD
Vecuronium—Bronchospasm—Bleomycin—melanoma	0.00226	0.0175	CcSEcCtD
Vecuronium—Face oedema—Carmustine—melanoma	0.00224	0.0174	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00224	0.0173	CcSEcCtD
Vecuronium—Face oedema—Temozolomide—melanoma	0.00217	0.0168	CcSEcCtD
Vecuronium—Anaphylactic shock—Vemurafenib—melanoma	0.00216	0.0167	CcSEcCtD
Vecuronium—Nervous system disorder—Vemurafenib—melanoma	0.00212	0.0164	CcSEcCtD
Vecuronium—Skin disorder—Vemurafenib—melanoma	0.0021	0.0162	CcSEcCtD
Vecuronium—Respiratory failure—Docetaxel—melanoma	0.00209	0.0162	CcSEcCtD
Vecuronium—Muscular weakness—Carmustine—melanoma	0.00205	0.0159	CcSEcCtD
Vecuronium—Injection site reaction—Docetaxel—melanoma	0.00204	0.0158	CcSEcCtD
Vecuronium—Hypotension—Vemurafenib—melanoma	0.00202	0.0156	CcSEcCtD
Vecuronium—Muscular weakness—Temozolomide—melanoma	0.00198	0.0153	CcSEcCtD
Vecuronium—Flushing—Bleomycin—melanoma	0.00171	0.0132	CcSEcCtD
Vecuronium—Erythema—Bleomycin—melanoma	0.0016	0.0124	CcSEcCtD
Vecuronium—Flushing—Dactinomycin—melanoma	0.00159	0.0123	CcSEcCtD
Vecuronium—Hypersensitivity—Vemurafenib—melanoma	0.00159	0.0123	CcSEcCtD
Vecuronium—Connective tissue disorder—Carmustine—melanoma	0.00158	0.0122	CcSEcCtD
Vecuronium—Connective tissue disorder—Temozolomide—melanoma	0.00153	0.0118	CcSEcCtD
Vecuronium—Erythema—Dactinomycin—melanoma	0.00149	0.0116	CcSEcCtD
Vecuronium—Flushing—Carmustine—melanoma	0.00149	0.0116	CcSEcCtD
Vecuronium—Flushing—Temozolomide—melanoma	0.00144	0.0112	CcSEcCtD
Vecuronium—Cardiac disorder—Temozolomide—melanoma	0.00144	0.0112	CcSEcCtD
Vecuronium—Angiopathy—Temozolomide—melanoma	0.00141	0.0109	CcSEcCtD
Vecuronium—Immune system disorder—Temozolomide—melanoma	0.0014	0.0109	CcSEcCtD
Vecuronium—Mediastinal disorder—Temozolomide—melanoma	0.0014	0.0108	CcSEcCtD
Vecuronium—Erythema—Carmustine—melanoma	0.0014	0.0108	CcSEcCtD
Vecuronium—Rash—Vemurafenib—melanoma	0.00136	0.0105	CcSEcCtD
Vecuronium—Dermatitis—Vemurafenib—melanoma	0.00136	0.0105	CcSEcCtD
Vecuronium—Erythema—Temozolomide—melanoma	0.00135	0.0105	CcSEcCtD
Vecuronium—Anaphylactic shock—Bleomycin—melanoma	0.00131	0.0101	CcSEcCtD
Vecuronium—Bronchospasm—Docetaxel—melanoma	0.00127	0.00983	CcSEcCtD
Vecuronium—Angioedema—Temozolomide—melanoma	0.00123	0.00957	CcSEcCtD
Vecuronium—Hypotension—Bleomycin—melanoma	0.00122	0.00947	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00114	0.00885	CcSEcCtD
Vecuronium—Tachycardia—Carmustine—melanoma	0.00111	0.00863	CcSEcCtD
Vecuronium—Anaphylactic shock—Temozolomide—melanoma	0.0011	0.00855	CcSEcCtD
Vecuronium—Nervous system disorder—Temozolomide—melanoma	0.00108	0.00838	CcSEcCtD
Vecuronium—Skin disorder—Temozolomide—melanoma	0.00107	0.0083	CcSEcCtD
Vecuronium—Hypotension—Carmustine—melanoma	0.00107	0.00826	CcSEcCtD
Vecuronium—Urticaria—Bleomycin—melanoma	0.00104	0.00805	CcSEcCtD
Vecuronium—Connective tissue disorder—Docetaxel—melanoma	0.00101	0.00786	CcSEcCtD
Vecuronium—Hypersensitivity—Bleomycin—melanoma	0.000963	0.00746	CcSEcCtD
Vecuronium—Cardiac disorder—Docetaxel—melanoma	0.000958	0.00742	CcSEcCtD
Vecuronium—Flushing—Docetaxel—melanoma	0.000958	0.00742	CcSEcCtD
Vecuronium—Angiopathy—Docetaxel—melanoma	0.000936	0.00726	CcSEcCtD
Vecuronium—Immune system disorder—Docetaxel—melanoma	0.000932	0.00723	CcSEcCtD
Vecuronium—Mediastinal disorder—Docetaxel—melanoma	0.00093	0.00721	CcSEcCtD
Vecuronium—Erythema—Docetaxel—melanoma	0.000898	0.00696	CcSEcCtD
Vecuronium—Hypersensitivity—Dactinomycin—melanoma	0.000898	0.00696	CcSEcCtD
Vecuronium—Urticaria—Temozolomide—melanoma	0.000876	0.00679	CcSEcCtD
Vecuronium—Hypersensitivity—Carmustine—melanoma	0.000841	0.00652	CcSEcCtD
Vecuronium—Rash—Bleomycin—melanoma	0.000824	0.00639	CcSEcCtD
Vecuronium—Dermatitis—Bleomycin—melanoma	0.000823	0.00638	CcSEcCtD
Vecuronium—Hypersensitivity—Temozolomide—melanoma	0.000812	0.0063	CcSEcCtD
Vecuronium—Rash—Dactinomycin—melanoma	0.000769	0.00596	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00076	0.00589	CcSEcCtD
Vecuronium—Anaphylactic shock—Docetaxel—melanoma	0.000733	0.00568	CcSEcCtD
Vecuronium—Shock—Docetaxel—melanoma	0.000721	0.00559	CcSEcCtD
Vecuronium—Rash—Carmustine—melanoma	0.000719	0.00558	CcSEcCtD
Vecuronium—Nervous system disorder—Docetaxel—melanoma	0.000719	0.00557	CcSEcCtD
Vecuronium—Dermatitis—Carmustine—melanoma	0.000719	0.00557	CcSEcCtD
Vecuronium—Tachycardia—Docetaxel—melanoma	0.000716	0.00555	CcSEcCtD
Vecuronium—Skin disorder—Docetaxel—melanoma	0.000712	0.00552	CcSEcCtD
Vecuronium—Rash—Temozolomide—melanoma	0.000695	0.00539	CcSEcCtD
Vecuronium—Dermatitis—Temozolomide—melanoma	0.000695	0.00538	CcSEcCtD
Vecuronium—Hypotension—Docetaxel—melanoma	0.000685	0.00531	CcSEcCtD
Vecuronium—Hypersensitivity—Docetaxel—melanoma	0.00054	0.00419	CcSEcCtD
Vecuronium—Rash—Docetaxel—melanoma	0.000462	0.00358	CcSEcCtD
Vecuronium—Dermatitis—Docetaxel—melanoma	0.000462	0.00358	CcSEcCtD
Vecuronium—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	7.27e-06	0.00982	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—GRIN2A—melanoma	6.94e-06	0.00938	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—GRIN2A—melanoma	6.59e-06	0.00891	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—GRIN2A—melanoma	6.25e-06	0.00845	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—STAT3—melanoma	6.01e-06	0.00812	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—NRAS—melanoma	5.99e-06	0.0081	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—MAPK3—melanoma	5.74e-06	0.00776	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	5.7e-06	0.00771	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	5.69e-06	0.00769	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	5.69e-06	0.00769	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—MAPK1—melanoma	5.46e-06	0.00738	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—GRIN2A—melanoma	5.32e-06	0.00719	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—KRAS—melanoma	5.16e-06	0.00697	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—GRIN2A—melanoma	5.05e-06	0.00683	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—SLC6A11—melanoma	4.96e-06	0.0067	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	4.85e-06	0.00656	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—PIK3CA—melanoma	4.74e-06	0.00641	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	4.65e-06	0.00629	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	4.61e-06	0.00623	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	4.6e-06	0.00622	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCB5—melanoma	4.45e-06	0.00601	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	4.43e-06	0.00598	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—HRAS—melanoma	4.39e-06	0.00593	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	4.29e-06	0.0058	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—PRKCA—melanoma	4.29e-06	0.0058	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	4.25e-06	0.00575	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	4.23e-06	0.00572	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	4.2e-06	0.00568	CbGpPWpGaD
Vecuronium—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	4.17e-06	0.00564	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	4.02e-06	0.00543	CbGpPWpGaD
Vecuronium—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—melanoma	3.87e-06	0.00523	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—FOXP3—melanoma	3.86e-06	0.00522	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	3.84e-06	0.00519	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—SLC6A11—melanoma	3.8e-06	0.00513	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—PRKCA—melanoma	3.65e-06	0.00493	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	3.57e-06	0.00483	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	3.52e-06	0.00476	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—PRKCA—melanoma	3.46e-06	0.00468	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	3.39e-06	0.00458	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	3.38e-06	0.00457	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—PRKCA—melanoma	3.29e-06	0.00444	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—BRAF—melanoma	3.16e-06	0.00427	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	3.15e-06	0.00426	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ARL2—melanoma	3.08e-06	0.00417	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—GRIN2A—melanoma	3.03e-06	0.00409	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	3.02e-06	0.00408	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	2.99e-06	0.00404	CbGpPWpGaD
Vecuronium—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	2.91e-06	0.00393	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	2.9e-06	0.00392	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	2.84e-06	0.00384	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—PRKCA—melanoma	2.79e-06	0.00378	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—BRAF—melanoma	2.68e-06	0.00363	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CTLA4—melanoma	2.66e-06	0.00359	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—PRKCA—melanoma	2.65e-06	0.00359	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—MDM2—melanoma	2.65e-06	0.00358	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	2.61e-06	0.00352	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—BRAF—melanoma	2.55e-06	0.00345	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	2.43e-06	0.00328	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—BRAF—melanoma	2.42e-06	0.00327	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	2.42e-06	0.00327	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	2.41e-06	0.00325	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.34e-06	0.00316	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—GRIN2A—melanoma	2.32e-06	0.00314	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	2.25e-06	0.00304	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.25e-06	0.00304	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—MDM2—melanoma	2.25e-06	0.00304	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	2.17e-06	0.00293	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	2.17e-06	0.00293	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—MDM2—melanoma	2.14e-06	0.00289	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CD86—melanoma	2.11e-06	0.00285	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	2.1e-06	0.00284	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL10—melanoma	2.07e-06	0.0028	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—BRAF—melanoma	2.06e-06	0.00278	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	2.04e-06	0.00276	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.04e-06	0.00276	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—MDM2—melanoma	2.03e-06	0.00274	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	2.01e-06	0.00272	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL4—melanoma	2.01e-06	0.00272	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	2e-06	0.00271	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—PDGFRA—melanoma	1.98e-06	0.00268	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—HLA-B—melanoma	1.97e-06	0.00266	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—BRAF—melanoma	1.95e-06	0.00264	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	1.94e-06	0.00263	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	1.94e-06	0.00263	CbGpPWpGaD
Vecuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	1.93e-06	0.00261	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—FASLG—melanoma	1.92e-06	0.0026	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—FAS—melanoma	1.85e-06	0.00251	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	1.84e-06	0.00249	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.84e-06	0.00248	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	1.83e-06	0.00247	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—HLA-A—melanoma	1.82e-06	0.00246	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—MAPK1—melanoma	1.81e-06	0.00244	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	1.81e-06	0.00244	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—MDM2—melanoma	1.72e-06	0.00233	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	1.67e-06	0.00225	CbGpPWpGaD
Vecuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	1.64e-06	0.00222	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—MDM2—melanoma	1.64e-06	0.00221	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	1.62e-06	0.00219	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—PRKCA—melanoma	1.59e-06	0.00215	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ACER3—melanoma	1.58e-06	0.00213	CbGpPWpGaD
Vecuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	1.56e-06	0.00211	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CD80—melanoma	1.54e-06	0.00208	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—MAPK1—melanoma	1.54e-06	0.00208	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—MAPK1—melanoma	1.46e-06	0.00197	CbGpPWpGaD
Vecuronium—CHRND—Transmission across Chemical Synapses—HRAS—melanoma	1.45e-06	0.00196	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UGT2B10—melanoma	1.44e-06	0.00195	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP8—melanoma	1.43e-06	0.00193	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—MAPK1—melanoma	1.39e-06	0.00187	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	1.37e-06	0.00185	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HS3ST5—melanoma	1.34e-06	0.00181	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	1.32e-06	0.00178	CbGpPWpGaD
Vecuronium—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	1.24e-06	0.00167	CbGpPWpGaD
Vecuronium—CHRNA1—Transmission across Chemical Synapses—HRAS—melanoma	1.23e-06	0.00167	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—PRKCA—melanoma	1.22e-06	0.00165	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IFNG—melanoma	1.22e-06	0.00164	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	1.2e-06	0.00162	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—MAPK1—melanoma	1.18e-06	0.00159	CbGpPWpGaD
Vecuronium—CHRNA2—Transmission across Chemical Synapses—HRAS—melanoma	1.17e-06	0.00158	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—BRAF—melanoma	1.17e-06	0.00158	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CXCL8—melanoma	1.13e-06	0.00153	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—MAPK1—melanoma	1.12e-06	0.00151	CbGpPWpGaD
Vecuronium—CHRND—Neuronal System—HRAS—melanoma	1.11e-06	0.0015	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP3—melanoma	1.08e-06	0.00146	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL2—melanoma	1.08e-06	0.00146	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	1.08e-06	0.00145	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.06e-06	0.00143	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PLCB4—melanoma	1.02e-06	0.00138	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.01e-06	0.00136	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	9.88e-07	0.00133	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MDM2—melanoma	9.82e-07	0.00133	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	9.77e-07	0.00132	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	9.68e-07	0.00131	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC6A11—melanoma	9.57e-07	0.00129	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIP4K2A—melanoma	9.57e-07	0.00129	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	9.49e-07	0.00128	CbGpPWpGaD
Vecuronium—CHRNA1—Neuronal System—HRAS—melanoma	9.46e-07	0.00128	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A5—melanoma	9.34e-07	0.00126	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	9.31e-07	0.00126	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTAP—melanoma	9.31e-07	0.00126	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ACER3—melanoma	9.26e-07	0.00125	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VEGFA—melanoma	9.18e-07	0.00124	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	9.15e-07	0.00124	CbGpPWpGaD
Vecuronium—CHRNA2—Neuronal System—HRAS—melanoma	8.98e-07	0.00121	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—BRAF—melanoma	8.98e-07	0.00121	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	8.97e-07	0.00121	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—melanoma	8.77e-07	0.00119	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	8.52e-07	0.00115	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UGT2B10—melanoma	8.46e-07	0.00114	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LUM—melanoma	8.29e-07	0.00112	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PHGDH—melanoma	8.29e-07	0.00112	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HPSE—melanoma	8.13e-07	0.0011	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	8.09e-07	0.00109	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	8.05e-07	0.00109	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CUBN—melanoma	7.98e-07	0.00108	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TNF—melanoma	7.87e-07	0.00106	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HS3ST5—melanoma	7.87e-07	0.00106	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SDHD—melanoma	7.71e-07	0.00104	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CSPG4—melanoma	7.71e-07	0.00104	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—BSG—melanoma	7.71e-07	0.00104	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	7.58e-07	0.00102	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MDM2—melanoma	7.52e-07	0.00102	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	7.49e-07	0.00101	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPAM—melanoma	7.47e-07	0.00101	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—melanoma	7.12e-07	0.000963	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	7.06e-07	0.000954	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	6.94e-07	0.000938	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	6.77e-07	0.000915	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MAPK1—melanoma	6.71e-07	0.000907	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	6.71e-07	0.000906	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	6.38e-07	0.000862	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PLA2G6—melanoma	6.35e-07	0.000858	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	6.06e-07	0.000819	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.97e-07	0.000807	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PLCB4—melanoma	5.96e-07	0.000806	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.88e-07	0.000795	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	5.75e-07	0.000778	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—VCAN—melanoma	5.7e-07	0.000771	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC6A11—melanoma	5.61e-07	0.000758	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIP4K2A—melanoma	5.61e-07	0.000758	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.47e-07	0.00074	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTAP—melanoma	5.45e-07	0.000737	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.45e-07	0.000737	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—melanoma	5.39e-07	0.000728	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	5.34e-07	0.000722	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	5.2e-07	0.000703	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	5.15e-07	0.000696	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MAPK1—melanoma	5.14e-07	0.000695	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.03e-07	0.00068	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.02e-07	0.000678	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.99e-07	0.000675	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PHGDH—melanoma	4.86e-07	0.000657	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LUM—melanoma	4.86e-07	0.000657	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP17A1—melanoma	4.81e-07	0.00065	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HPSE—melanoma	4.77e-07	0.000644	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CUBN—melanoma	4.68e-07	0.000633	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GNA11—melanoma	4.54e-07	0.000614	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.53e-07	0.000613	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SDHD—melanoma	4.52e-07	0.000611	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CSPG4—melanoma	4.52e-07	0.000611	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—BSG—melanoma	4.52e-07	0.000611	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	4.46e-07	0.000602	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—FASN—melanoma	4.45e-07	0.000601	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPAM—melanoma	4.38e-07	0.000592	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC5A5—melanoma	4.37e-07	0.000591	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.29e-07	0.00058	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GNAQ—melanoma	4.23e-07	0.000571	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CD44—melanoma	4.23e-07	0.000571	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.17e-07	0.000564	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—HRAS—melanoma	4.13e-07	0.000558	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.08e-07	0.000551	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.08e-07	0.000551	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1B1—melanoma	4.05e-07	0.000547	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.88e-07	0.000525	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.85e-07	0.000521	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PLA2G6—melanoma	3.72e-07	0.000503	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.54e-07	0.000478	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.42e-07	0.000463	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—VCAN—melanoma	3.34e-07	0.000452	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCB1—melanoma	3.34e-07	0.000451	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PRKCA—melanoma	3.07e-07	0.000415	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ERCC2—melanoma	3.04e-07	0.000412	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.89e-07	0.000391	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP17A1—melanoma	2.82e-07	0.000381	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GNA11—melanoma	2.66e-07	0.00036	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.61e-07	0.000353	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—FASN—melanoma	2.61e-07	0.000352	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC5A5—melanoma	2.56e-07	0.000347	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GNAQ—melanoma	2.48e-07	0.000335	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CD44—melanoma	2.48e-07	0.000335	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CG—melanoma	2.4e-07	0.000325	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1B1—melanoma	2.37e-07	0.000321	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPARG—melanoma	2.32e-07	0.000314	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CD—melanoma	2.11e-07	0.000286	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALB—melanoma	2.09e-07	0.000282	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CB—melanoma	1.84e-07	0.000249	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGS2—melanoma	1.83e-07	0.000247	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PRKCA—melanoma	1.8e-07	0.000243	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ERCC2—melanoma	1.78e-07	0.000241	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTEN—melanoma	1.59e-07	0.000215	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CG—melanoma	1.41e-07	0.00019	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPARG—melanoma	1.36e-07	0.000184	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CD—melanoma	1.24e-07	0.000167	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALB—melanoma	1.22e-07	0.000165	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CA—melanoma	1.12e-07	0.000152	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CB—melanoma	1.08e-07	0.000146	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGS2—melanoma	1.07e-07	0.000145	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTEN—melanoma	9.33e-08	0.000126	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKT1—melanoma	9.18e-08	0.000124	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CA—melanoma	6.58e-08	8.9e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKT1—melanoma	5.38e-08	7.27e-05	CbGpPWpGaD
